Gene-edited CAR T therapy is opening rare disease treatment in 2026. Here’s what CRISPR, AEGIS, and off-the-shelf T cells actually mean.
Gene-edited CAR T therapy is opening rare disease treatment in 2026. Here’s what CRISPR, AEGIS, and off-the-shelf T cells actually mean.